MIAMI, Oct. 05, 2017 -- Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management, has submitted its application for OTCQB listing.
During the 3rd quarter of the year, Progressive Care worked to meet the listing requirements of OTCQB which include a minimum bid price of $0.01, not being in bankruptcy, being timely and current with reporting standards, 2 independent board members, and a majority independent audit committee. With the addition of Mr. Jervis Hough and Mr. Oleg Firer as independent board members and members of the audit committee, the Company met all of the initial requirements to file an application with OTC Markets for a change in listing tier to OTCQB. This application has been submitted to OTC Markets for review.
“We are excited to get the uplist process started,” stated S. Parikh Mars, CEO. “We expect OTC Markets to review our application quickly as we are prepared to comply with all document requests and listing standards. We believe that the change in listing tier on OTC Markets will help the company reach a wider audience and give our shareholders increased confidence.”
About Progressive Care
Progressive Care Inc. (OTC PINK:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Contact
Armen Karapetyan
Senior Advisor Business Development
[email protected]


Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions 



